发明名称 |
Predicting risk of major adverse cardiac events |
摘要 |
Measurement of circulating ST2 and natriuretic peptide (e.g., NT-proBNP) concentrations is useful for the prognostic evaluation of subjects, in particular for the prediction of adverse clinical outcomes, e.g., mortality, transplantation, and heart failure. |
申请公布号 |
EP2827152(B1) |
申请公布日期 |
2016.06.08 |
申请号 |
EP20140177846 |
申请日期 |
2009.04.17 |
申请人 |
CRITICAL CARE DIAGNOSTICS, INC. |
发明人 |
SNIDER, JAMES V;HEYMAN, EUGENE R |
分类号 |
G01N33/74;C12Q1/68;G01N33/68 |
主分类号 |
G01N33/74 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|